KR20230113770A9 - 고순도 β 니코틴아미드 모노뉴클레오티드(NMN) 및 그 제조 방법 - Google Patents

고순도 β 니코틴아미드 모노뉴클레오티드(NMN) 및 그 제조 방법

Info

Publication number
KR20230113770A9
KR20230113770A9 KR1020237021520A KR20237021520A KR20230113770A9 KR 20230113770 A9 KR20230113770 A9 KR 20230113770A9 KR 1020237021520 A KR1020237021520 A KR 1020237021520A KR 20237021520 A KR20237021520 A KR 20237021520A KR 20230113770 A9 KR20230113770 A9 KR 20230113770A9
Authority
KR
South Korea
Prior art keywords
nmn
producing
same
high purity
nicotinamide mononucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237021520A
Other languages
English (en)
Korean (ko)
Other versions
KR20230113770A (ko
Inventor
츠네마루 다나카
메구미 다나카
류지 히라마츠
다이조 시마무라
Original Assignee
미라이랩 바이오사이언스 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미라이랩 바이오사이언스 인코퍼레이티드 filed Critical 미라이랩 바이오사이언스 인코퍼레이티드
Publication of KR20230113770A publication Critical patent/KR20230113770A/ko
Publication of KR20230113770A9 publication Critical patent/KR20230113770A9/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/02—Pentosyltransferases (2.4.2)
    • C12Y204/02007—Adenine phosphoribosyltransferase (2.4.2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/06—Diphosphotransferases (2.7.6)
    • C12Y207/06001—Ribose-phosphate diphosphokinase (2.7.6.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07001—Nicotinamide-nucleotide adenylyltransferase (2.7.7.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/02—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2) hydrolysing N-glycosyl compounds (3.2.2)
    • C12Y302/02004—AMP nucleosidase (3.2.2.4)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
KR1020237021520A 2020-11-27 2021-11-26 고순도 β 니코틴아미드 모노뉴클레오티드(NMN) 및 그 제조 방법 Pending KR20230113770A9 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020197381 2020-11-27
JPJP-P-2020-197381 2020-11-27
PCT/JP2021/043333 WO2022114105A1 (ja) 2020-11-27 2021-11-26 高純度βニコチンアミドモノヌクレオチド（ＮＭＮ）及びその製造方法

Publications (2)

Publication Number Publication Date
KR20230113770A KR20230113770A (ko) 2023-08-01
KR20230113770A9 true KR20230113770A9 (ko) 2024-03-25

Family

ID=81754422

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237021520A Pending KR20230113770A9 (ko) 2020-11-27 2021-11-26 고순도 β 니코틴아미드 모노뉴클레오티드(NMN) 및 그 제조 방법

Country Status (6)

Country Link
US (1) US20230416291A1 (https=)
EP (1) EP4253396A4 (https=)
JP (1) JPWO2022114105A1 (https=)
KR (1) KR20230113770A9 (https=)
CN (1) CN116528696A (https=)
WO (1) WO2022114105A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025183464A (ja) * 2022-11-04 2025-12-17 ミライラボバイオサイエンス株式会社 イヌの腸内細菌叢改善用剤
JPWO2024225432A1 (https=) * 2023-04-28 2024-10-31

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
ES2333539T3 (es) * 2006-04-21 2010-02-23 Cellzome Limited Derivados de terfenilo para el tratamiento de la enfermedad de alzheimer.
JP2014527955A (ja) * 2011-06-29 2014-10-23 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ 糖質コルチコイド介在性障害の処置のための、インダゾリルアミド誘導体の結晶形
WO2015069860A1 (en) 2013-11-06 2015-05-14 President And Fellows Of Harvard College Biological production of nad precursors and analogs
KR20150069860A (ko) 2013-12-16 2015-06-24 송석록 낚시용 자석 봉돌
GB2542881B (en) * 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
DE102016105985A1 (de) 2016-04-01 2017-10-05 Wipotec Wiege- Und Positioniersysteme Gmbh Verfahren und Vorrichtung zur Laserbearbeitung
WO2017185549A1 (zh) 2016-07-30 2017-11-02 邦泰生物工程(深圳)有限公司 一种制备烟酰胺单核苷酸的方法2
JP6712356B2 (ja) * 2016-07-30 2020-06-17 邦泰生物工程（深▲セン▼）有限公司 ニコチンアミドホスホリボシルトランスフェラーゼ突然変異体及びその応用
WO2018023205A1 (zh) * 2016-07-30 2018-02-08 邦泰生物工程(深圳)有限公司 一种烟酰胺单核苷酸的纯化方法
WO2018047715A1 (ja) * 2016-09-06 2018-03-15 協和発酵バイオ株式会社 β－ニコチンアミドモノヌクレオチドの結晶及びその製造方法
CN108530505A (zh) * 2017-03-02 2018-09-14 江苏康缘药业股份有限公司 一种黄酮苷类化合物及其制备方法和应用
CN108530504B (zh) * 2017-03-02 2021-10-22 江苏康缘药业股份有限公司 一种化合物及其制备方法和应用
CN110483601A (zh) * 2019-08-12 2019-11-22 上海龙翔生物医药开发有限公司 制备β-烟酸胺单核苷酸的方法及其应用
CN110845548B (zh) * 2019-11-22 2021-02-09 武汉一若生物材料有限公司 一种制备β-烟酰胺单核苷酸及其钠盐的方法
CN111187759A (zh) * 2020-01-19 2020-05-22 杭州唯泰生物药业有限公司 用于制备烟酰胺单核苷酸的酶组合物及酶法制备烟酰胺单核苷酸的方法
CN111377983B (zh) * 2020-03-26 2023-05-16 音芙医药科技(上海)有限公司 一种β-烟酰胺单核苷酸的制备方法
CN111568913A (zh) * 2020-05-18 2020-08-25 厦门医学院 黄酮c-苷类化合物的用途

Also Published As

Publication number Publication date
EP4253396A4 (en) 2024-09-11
US20230416291A1 (en) 2023-12-28
KR20230113770A (ko) 2023-08-01
EP4253396A1 (en) 2023-10-04
WO2022114105A1 (ja) 2022-06-02
JPWO2022114105A1 (https=) 2022-06-02
CN116528696A (zh) 2023-08-01

Similar Documents

Publication Publication Date Title
KR20230113770A9 (ko) 고순도 β 니코틴아미드 모노뉴클레오티드(NMN) 및 그 제조 방법
EP3372606A4 (en) CRYSTAL FORM, METHOD OF MANUFACTURE AND INTERMEDIATE PRODUCT OF A DIHYDROPYRIDORIN COMPOUND
PH12019500493A1 (en) Solvate form of (r)-2-amino-3-phenylpropyl carbamate
IL316669B2 (en) Method for preparing nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof
EP4224376A4 (en) Quantum circuit, quantum computer, and method for producing quantum circuit
MA49696A (fr) Sel d'un composé dérivé d'aminopyridine, forme cristalline de celui-ci, et son procédé de préparation
EP4317191A4 (en) Modified nicotinamide phosphoribosyltransferase
PL4066549T3 (pl) Sposób synchronizacji
EP3636429A4 (en) MULTILAYERED STRUCTURE AND METHOD FOR PRODUCING A MULTILAYERED STRUCTURE
EP3453679A4 (en) HIGHLY PURE TOLEPHOLE TACHLORIDE AND METHOD FOR PRODUCING THE SAME
PL3990414T3 (pl) Sposób wytwarzania zagęszczonego wyrobu związanego węglanem
EP4151784A4 (en) FAST ONE-STEP GRADIENT METHOD FOR THE GENERATION OF NANOANTIBODIES
EP3771301A4 (en) INSULATED CIRCUIT BOARD AND METHOD OF MAKING AN INSULATED CIRCUIT BOARD
EP4597274A4 (en) SYNCHRONIZATION METHOD BETWEEN ACTIVE STYLUS AND TOUCHSCREEN, ACTIVE STYLUS AND TOUCHSCREEN
GB2609357B (en) Wearable article, assembly, and method of making the same
ZA202306906B (en) Method for producing ac-225 solution and method for producing medicine using ac-225 solution
EP4053110A4 (en) FOUR-MEMBED RING DERIVATIVE MODIFIER, METHOD FOR PRODUCING THEREOF AND ITS USE
IL315082A (en) Antiviral compounds and methods for its production and use
EP3842571A4 (en) ANODE FOR ELECTROLYTIC SYNTHESIS AND METHOD FOR PRODUCING FLUORINE GAS
EP3789481A4 (en) TRANSFORMANTS OF CORYNEFORM BACTERIA AND PRODUCTION PROCESSES FOR USEFUL COMPOUND THEREOF
IL326322A (en) Antiviral compounds and methods for their production and use
BR112021016787A2 (pt) Método para preparar 6-(1-acriloilpiperidin-4-il)-2-(4-fenoxifenil)nicotinamida
EP3991795A4 (en) NOVEL USE OF NICOTINAMIDE MONONUCLEOTIDE (NMN) AND NICOTINAMIDE RIBOSIDE (NR)
IL311041A (en) Lymphocyte population and methods for their production
HUE062721T2 (hu) Homlokzat, valamint eljárás annak elõállítására

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230626

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction

Patent event code: PG17011E01I

Patent event date: 20240319

Comment text: Request for Publication of Correction

Publication date: 20240325

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20241023

Comment text: Request for Examination of Application